Vahdam targets Rs 1,000 crore by FY30 as supplements, quick commerce power India growth

Vahdam Teas is targeting Rs 1,000 crore in revenue by FY30, with India expected to contribute 20% of sales. The brand expects more than Rs 500 crore in revenue this fiscal and is prioritising supplements, D2C and quick-commerce expansion over a major offline retail push.

— Source publishedTue, 4 Aug, 2026, 08:28 IST·First seen Tue, 4 Aug, 2026, 09:26 IST·Source ET Retail

What happened

Vahdam Teas targets Rs 1,000 crore revenue by FY30, with India rising to 20% of sales through herbal supplements, D2C and quick commerce. The brand expects over

Key facts

  • Rs 1,000 crore revenue target by FY30
  • FY26 revenue around Rs 350 crore
  • Rs 500 crore-plus annualised revenue run rate
  • Over Rs 500 crore net revenue expected this fiscal
  • 30% growth last year; over 50% expected this fiscal
  • India revenue share: 5% in FY26, around 8% this fiscal, 20% by FY30
  • India business Rs 40 crore-plus run rate; Rs 100 crore target run rate within six months
  • India TAM estimated at Rs 5,000-6,000 crore
  • Supplements contribute nearly 65% of India business
  • Quick commerce contributes around 10% of India revenue
  • Around 50 core India SKUs
  • 125,000 sq ft Noida facility at nearly 55% utilisation
  • Potential supplements-capacity investment below $1 million
  • FY26 EBITDA Rs 17 crore

Why this matters

Partnership or acquisition opportunities should center on supplement formulations, rapid-delivery distribution and digital customer acquisition capabilities that can accelerate Vahdam’s India expansion without requiring capital-heavy offline retail.

What to watch

  • Quarterly India revenue share and whether it rises materially above the current roughly 8% base.
  • Supplements' share of India sales, repeat-purchase rates and gross margin relative to tea.
  • Quick-commerce contribution, average order value, promotional intensity and net contribution after commissions.
  • Evidence of D2C customer-acquisition-cost increases or subscription/retention improvement.
  • New offline distribution partnerships in pharmacy, premium grocery or travel retail.
  • Regulatory developments affecting nutraceutical ingredients, labeling or wellness claims.
  • Whether revenue crosses Rs 500 crore this fiscal and the implied CAGR needed to reach Rs 1,000 crore by FY30.
  • Expand supplements into condition- and occasion-led routines such as sleep, gut health, immunity, energy and women’s wellness, using teas as a cross-sell vehicle.
  • Prioritize quick-commerce-exclusive packs, trial sizes, bundles and replenishment subscriptions rather than simply replicating D2C assortment.
  • Build first-party retention through quizzes, regimen recommendations, loyalty and subscription programs to offset marketplace and quick-commerce acquisition costs.
  • Use selective offline placement in premium grocery, pharmacies, airports, corporate gifting and wellness-led retail rather than broad general-trade expansion.
  • Strengthen clinical substantiation, compliant labeling and ingredient transparency before scaling health-oriented claims.
  • Localize India pricing and pack architecture to widen access without eroding the premium export-led brand perception.

Also reported by